J&J Plant Halts Production After FDA Finds Bacteria

Law360, New York (May 5, 2010, 1:17 PM EDT) -- Johnson & Johnson has shut down a Philadelphia-area plant that was the source of recalled children's medicine, following a U.S. Food and Drug Administration inspection that uncovered bacterial contamination, dust and grime at the site.

Details of the FDA's late April visits to the factory in Fort Washington, Pa., came out in a report the agency released Tuesday, the same day J&J announced it was stopping production at the plant.

Deborah Autor, the director of the FDA's Office of Compliance, urged consumers to use other private...
To view the full article, register now.